D-0300-2026 Class III Ongoing

Recalled by NOVADOZ PHARMACEUTICALS LLC — Piscataway, NJ

FDA drug recall D-0300-2026 was initiated by NOVADOZ PHARMACEUTICALS LLC on Dec 15, 2025 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Feb 4, 2026
Initiation Date
Dec 15, 2025
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

US Nationwide.

Code information

Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0300-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0300-2026. Report a data issue: hello@regdatalab.com.